Johnson & Johnson is the top pharma company advertising in print medical journals through Q2 2014

Johnson & Johnson spent almost $21 million in the first half of 2014, advertising drug products in professional health journals, according to  Kantar Media . Johnson & Johnson makes up 7% of the total advertising share. GlaxoSmithKline is the second company on the list, but has spent less than half of Johnson & Johnson.

Top 5 Print Ad Pharma Companies (Dollars): June 2014

  1. Johnson & Johnson – $21 MM (+5%)
  2. GlaxoSmithKline – $8 MM (+135%)
  3. Takeda – $7 MM (+1,233%)
  4. Pfizer – $7 MM (-17%)
  5. Novartis - $7 MM (+16%)

The percentage changes compare June 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.



Search article